MOLCURE

Company facts

• Founded

  2013

  ReportedSource for founded (opens in new tab)

• Headquarters

  Japan (Kawasaki)

  ConfirmedSource for headquarters (opens in new tab)

Latest funding round

Drug discovery partners

2 pharma, 2 other. Pharma here means a company with approved products and roughly $1B or more in annual revenue.

• Boehringer Ingelheim Pharma

  Multi-year strategic research agreement for antibody discovery (multiple targets), Oct 7, 2025

  Terms not disclosed

  ConfirmedSource for Boehringer Ingelheim (opens in new tab)

• Ono Pharmaceutical Pharma

  Antibody drug discovery collaboration (multiple targets, Ono option rights), Mar 23, 2023

  Terms not disclosed

  ConfirmedSource for Ono Pharmaceutical (opens in new tab)

• KM Biologics Biotech

  Research agreement for biopharmaceutical discovery in hematology, Jan 28, 2026

  Terms not disclosed

  ConfirmedSource for KM Biologics (opens in new tab)

• Teijin Pharma Biotech

  Joint research on lead antibody optimization for central nervous system diseases, Jan 9, 2025

  Terms not disclosed

  ConfirmedSource for Teijin Pharma (opens in new tab)

Recent news

• Oct 6, 2026

  Exhibits and speaks at BioJapan 2026

  ConfirmedSource (opens in new tab)

• Apr 16, 2026

  Full-scale launch of co-creation with Hitachi on services built on Hitachi's Confidential AI Platform

  ConfirmedSource (opens in new tab)

• Mar 5, 2026

  Wins the Applied Intelligence Award at XTC JAPAN 2026

  ConfirmedSource (opens in new tab)

• Sep 18, 2025

  Completed first joint research with Teijin Pharma; signed new contract

  ConfirmedSource (opens in new tab)